The global omega-3 fatty acids market size 2026 represents a dynamic and rapidly expanding sector within the health and nutrition industry. Valued at USD 1.98 billion in 2024, the market is projected to grow from USD 2.11 billion in 2025 to USD 3.56 billion by 2032, exhibiting a CAGR of 7.77% during the forecast period. This substantial growth trajectory reflects the increasing global awareness of health benefits associated with polyunsaturated fatty acids and their critical role in preventive healthcare.
Omega-3 fatty acids comprise essential polyunsaturated fats vital for human health, including different types such as EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid), and ALA (alpha-linolenic acid). These nutrients cannot be produced by the human body and must be obtained through dietary sources or supplements. The market's expansion is driven by manufacturers exploring novel functional ingredients and developing innovative delivery methods to capitalize on emerging health trends.
Regional Analysis
Asia Pacific dominated the omega-3 fatty acids market with a market share of 34.34% in 2024. The region is estimated to reach USD 0.73 billion in 2025, positioning it as the largest market globally. This dominance stems from rising health awareness, increasing discretionary incomes, and rapid demand growth for dietary supplements in highly populated countries like China and India. The region's growth rate is expected to exceed the global average, supported by the increasing popularity of functional foods and beverages.
North America holds the second-largest market position, valued at USD 0.56 billion in 2024. The U.S. market alone is estimated to reach USD 0.49 billion in 2025. Growth in this region is attributed to heightened awareness about the positive health effects of polyunsaturated fatty acids, an aging population, and the prevalence of lifestyle-related health conditions. American consumers increasingly incorporate nutritional supplements into preventive health routines, recognizing omega-3s for their cardiovascular, brain, joint, and eye health benefits.
Europe secured the third-largest regional position, estimated to reach USD 0.55 billion in 2025. European consumers demonstrate high health consciousness and proactive approaches to preventive nutrition. The aging populations in countries such as Germany, Italy, and France represent major consumer segments for omega-3 supplements supporting cardiovascular and cognitive health. The region is projected to record a growth rate of 7.18% during the forecast period.
Get a Free Sample PDF Of This Report - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/omega-3-fatty-acids-market-100248
Market Segmentation
By Source
The market divides into several source categories: algae oil, fish oil, krill oil, concentrates, plant and seed oil, and others. The concentrates segment accounted for the largest market share during the forecast period, containing 30-70% combined EPA and DHA, which provides 2-3 times the active Omega-3 content compared to conventional oil. This higher potency makes concentrates ideal for nutraceutical and pharmaceutical formulations.
The plant and seed oil segment is expected to grow at a CAGR of 8.76% over the forecast period. Growing concerns related to sustainability practices and overexploitation of traditional marine sources support this segment's growth trajectory. Algae oil and flax seeds have emerged as important omega-3 sources perfect for consumers following vegetarian diets.
By Type
DHA accounts for the largest market share in 2024. This dominance is scientifically justified as DHA provides proven neurological benefits and is widely used in infant nutrition products and cognitive health supplements. DHA is legally required in all infant formulas sold in the EU and in many Asian and South American markets, further supporting segment growth.
EPA represents another major type expected to grow by 7.97% during the forecast period. EPA is used in prescription drugs approved by regulatory bodies including the U.S. FDA, EMA, and Japan's PMDA, helping treat hypertriglyceridemia, inflammation, and cardiovascular risk among high-risk patients.
By Application
The dietary supplements segment accounts for the largest omega-3 fatty acids market share in 2024. Omega-3 supplements support improved heart and cardiovascular health, enhanced brain and cognitive function, and joint, eye, and immune health. Consumers increasingly consume omega-3 supplements as part of preventive healthcare regimes. The segment's growth is strengthened by official endorsements from regulatory agencies such as the FDA, EFSA, AHA, and WHO, which enhance trust among consumers and medical practitioners.
Infant formula sales are expected to grow 7.48% during the forecast period. DHA and EPA have been recognized as vital nutrients in babies' early life nutrition, prompting several countries to adopt regulations mandating their inclusion in most infant formula formulations.
Market Drivers and Opportunities
The primary driver for market growth is the rising awareness of health benefits associated with polyunsaturated fatty acids. Recent recognition of positive health effects has created substantial demand for omega-3 fatty acids across various applications including dietary supplements, functional foods, and pharmaceuticals. Clinical studies increasingly suggest that PUFA consumption primarily supports chronic disease management, particularly cardiovascular problems, while supporting various other bodily functions.
The growing awareness regarding omega fatty acid benefits and the importance of essential fatty acids fuels demand for long-chain PUFAs. In recent years, omega fatty acids have gained remarkable popularity as they cannot be produced by the body and must be administered externally through omega-3 rich diets or dietary supplements.
A significant market opportunity exists in infant nutrition. Manufacturers can develop product lines specifically for this segment as mandatory DHA inclusion guidelines are adopted by several countries in Europe, China, and South America. Increased demand for plant-based raw materials also creates opportunities for vegan supplements, infant formula, and fortified foods.
Market Trends
Expansion of preventive and cognitive health applications represents a key trend impacting the market. Omega-3 (EPA/DHA) is increasingly positioned in the supplements market as a key ingredient supporting brain, heart, and eye health beyond basic nutrition. Growing evidence links omega-3 intake to mental wellness and cognitive performance, driving its inclusion in premium product manufacturing.
Several food manufacturers are integrating omega-3 into dairy, bakery, beverages, and infant formula products. They adopt various production technologies including microencapsulation and emulsification to improve taste, stability, and shelf life. These technological advancements enable stable incorporation of omega-3 into diverse food products without affecting sensory qualities.
Competitive Landscape
The global market structure is moderately consolidated with major players including Evonik, BASF SE, Royal DSM N.V., Lonza, and Epax. These industry leaders work toward further consolidation by acquiring smaller market participants. Partnerships, agreements, and investment in research and development represent key strategies adopted to strengthen market positions.
The entry of small and niche players escalates competition and adds stimulus to market growth. Key players' exploration of novel sources for omega-3 significantly contributes to market expansion. Companies are expanding manufacturing facilities in India, China, and other Southeast Asian countries to capitalize on regional growth opportunities.
Purchase the full report here - https://www.fortunebusinessinsights.com/select-license/100248
Recent Industry Developments
Recent product launches demonstrate ongoing innovation in the omega-3 market. In March 2025, Natac launched Omega-3 Star, manufactured using high-quality fish oil and specially designed for application in food, nutraceutical, and pet nutrition industries. In October 2023, dsm-firmenich announced the launch of life's OMEGA O3020 in North America, representing the first and only single-source algal omega-3 with the same EPA to DHA ratio naturally found in standard fish oil but with higher efficacy.
Nature's Bounty introduced a new Plant-Based Omega-3 dietary supplement in October 2022, composed of 1,000 mg of vegetarian algae oil supporting heart, joint, and skin health. These developments reflect the industry's commitment to innovation and meeting diverse consumer preferences for both marine and plant-based omega-3 sources.
Conclusion
The omega-3 fatty acids market stands poised for substantial growth through 2032, driven by increasing health awareness, expanding applications across multiple industries, and technological innovations in extraction and formulation. The market's evolution from traditional fish oil sources to include plant-based alternatives demonstrates responsiveness to consumer preferences for sustainability and dietary restrictions. With strong growth across all major regions and continuous product innovation by key industry players, the omega-3 fatty acids market represents a dynamic sector within the broader health and nutrition industry, offering significant opportunities for manufacturers, investors, and stakeholders committed to promoting preventive healthcare and nutritional wellness globally.